Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
Lo C, Toyama T, Wang Y, et al.
Cochrane Systematic Review. Pub online 24 September 2018.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Lo C, Toyama T, Wang Y, et al.
Cochrane Systematic Review. Pub online 24 September 2018.
Leggi
Zelniker TA, Braunwald E
Journal of the American College of Cardiology. 2018;72(15):1845-55
Leggi
Rezende PC, Everett BM, Brooks MM, et al.
Journal of the American College of Cardiology. 2018;72(15):1778-86
Leggi
Schwarz PEH, Timpel P, Harst L, et al.
Journal of the American College of Cardiology. 2018;72(15):1829-44
Leggi
Newman JD, Vani AK, Aleman JO, et al.
Journal of the American College of Cardiology. 2018;72(15):1856-69
Leggi
Miettinen Maija E, Virtanen Suvi M
BMJ 2018;362:k3867
Leggi
Antvorskov JC, Halldorsson TI, Josefsen K, et al.
BMJ 2018;362:k3547
Leggi
Susan Z. Yanovski SZ
JAMA 2018;320(11):1111-3
Leggi
LeBlanc ES, Patnode CD, Webber EM, et al.
JAMA 2018;320(11):1172-91
Leggi
Game F, Jeffcoate W, Tarnow L, et al.
Lancet Diabetes Endocrinol. September 19, 2018
Leggi